Bank Of Marin Abbott Laboratories Transaction History

Bank Of Marin

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $17,871 - $20,965	188 Added 3.14%	6,166 $677,000
Q3 2022 Nov 09, 2022	SELL	$96.76 - $112.03 $63,861 - $73,939	-660 Reduced 9.94%	5,978 $578,000
Q2 2022 Aug 16, 2022	SELL	$102.07 - $123.37 $125,546 - $151,745	-1,230 Reduced 15.63%	6,638 $721,000
Q4 2021 Feb 15, 2022	BUY	$115.53 - $141.46 $22,643 - $27,726	196 Added 2.55%	7,868 $1.11 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $206,021 - $227,919	1,766 Added 29.9%	7,672 $906,000
Q2 2021 Aug 09, 2021	SELL	$105.79 - $124.53 $48,134 - $56,661	-455 Reduced 7.15%	5,906 $685,000
Q4 2020 Feb 10, 2021	BUY	$105.0 - $114.42 $11,235 - $12,242	107 Added 1.71%	6,361 $697,000
Q2 2020 Aug 12, 2020	SELL	$76.57 - $98.0 $132,159 - $169,148	-1,726 Reduced 21.63%	6,254 $572,000
Q1 2020 May 13, 2020	BUY	$62.82 - $91.86 $31,410 - $45,930	500 Added 6.68%	7,980 $629,000
Q4 2019 Feb 12, 2020	BUY	$78.51 - $87.4 $587,254 - $653,752	7,480 New	7,480 $650,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Bank Of Marin, based on Form 13F filings with the SEC.

Stay updated on Bank Of Marin with notifications on news.